Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTiton Regulatory News (TON)

Share Price Information for Titon (TON)

Share Price is delayed by 15 minutes
Get Live Data
80.00    0.00 (0.00%)
Bid:
75.00
Ask:
85.00
Spread: 10.00 (13.333%)
Market Cap: £9.00m
TON Live PriceLast checked at - London Stock Exchange

Intraday Titon Share Chart

Trading Update and Board Change

11 Jul 2024 07:00

RNS Number : 9500V
Titon Holdings PLC
11 July 2024
 

LEI: 213800ZHXS8G27RM1D97

 

This announcement contains inside information for the purposes of Article 7 of the UK version of the Market Abuse Regulation (EU) No.596/2014, which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018.

11 July 2024

 

Titon Holdings Plc

 

Trading Update and Board Change

 

Titon Holdings Plc ("Titon", the "Group" or the "Company") provides the following update on the Group's performance for the year to 30 September 2024 ("FY23/24").

 

Continued subdued market demand and construction delays, leading to slow conversion of orders into sales, have presented on-going challenging trading conditions since the update in the Company's interim results statement on 15 May 2024. As a result, trading in the UK and Europe through to the end of the FY23/24 period is expected to be below the Group's prior expectations, leading to an increased expected loss for the period. Through careful cost control and working capital management we are mitigating the effect on cash.

On a year-on-year basis, sales in our Ventilation Systems business unit have reduced. However, in recent months we have seen a reversal of this trend and are currently seeing modest growth returning. Encouragingly, we have seen strong growth in our order book, which has increased by 18% since the start of the calendar year but market delays have meant these orders are yet to convert into sales. Had they converted, revenues would have returned to the levels we saw during the first half of FY23. The Company believes that its product offering in this division is strong and margins are competitive, and whilst a wider go-to-market strategy needs to be further developed, we are confident that we will continue to grow our market share.

Sales in our Window and Door Hardware ("WDH") business unit have been slow in the UK throughout the financial year, balanced slightly by increasing sales into Europe, albeit from a low base. The UK sales trend is due to a combination of market-wide demand factors and our sales methodologies. We are addressing our WDH sales strategy accordingly.

Following the arrival of the Group's new Chief Executive two months ago, the Board and executive team have led an initial review of the strategy of the business. We have also outlined some initial cost reduction actions.

The forecast for Titon Korea remains unchanged since the previous update.

Healthy balance sheet

The Group continues to maintain a healthy balance sheet with no indebtedness and with cash of £2.1m.

Board Change

The Group also announces that Tyson Anderson will step down from the Board and leave the business with effect from today as a result of a wider restructuring to reduce the cost base of the business.

 

Tom Carpenter, Chief Executive, commented:

"It is well known that the UK and European new build market has been depressed which has affected many of Titon's customers and industry peers. As a result, the Company continues to face challenges with lower sales than last anticipated. We are now seeing growth in our Ventilation Systems sales and I am encouraged by the attractiveness of our product offering and recent strong order intake in this division. Unfortunately, this growth is being offset by an erosion of sales in our WDH business unit. We are taking immediate actions to improve our sales approach in this division. 

As a result of the strategic review, we have initiated several actions to return the Group to profitability:

Ventilation Systems Growth: This market is expanding and offers competitive margins. We are seeing increases in order intake and anticipate further opportunities by winning specifications at the national construction company level and entering adjacent markets. To capitalise on these opportunities, we are creating a new Business Development role to drive sales in these segments.

WDH Sales Strategy: Our current approach to selling in the UK WDH market hasn't been meeting our expectations. Therefore, we are shifting our WDH sales approach, enhancing our website, and transitioning our direct sales team to focus on new business development.

Research and Development: While R&D remains crucial, spending will be adjusted to reflect our financial situation, focusing even more on projects that promise earlier returns and/or product margin improvements.

Marketing: To succeed, we need to improve our market positioning and have a clear value proposition for both our core business units. We are launching a new inbound marketing program to ensure decision-makers know who we are and why they should buy from us.

Margin Enhancement: We are not achieving the gross margins our products are capable of achieving. Therefore, we have initiated a company wide gross margin improvement program. Our goal is to realise meaningful gross margin improvements over the next 12-18 months.

Cost Reductions:. We have achieved some cost efficiencies throughout the year and as of today we are undertaking some further reductions in headcount, while also continually exploring other cost saving opportunities.

We also continue to explore options regarding the strategic fit of our Korean joint ventures.

Despite these challenges, I am optimistic about Titon's future. We have a great range of products and I am confident that with focus and hard work we will ultimately be successful. We are making good progress on our strategic plan and look forward to sharing this more widely in due course. We thank our employees, customers and shareholders for their continued support."

 

 

For further information please contact:

 

Titon Holdings Plc

Tom Carpenter

Carolyn Isom

 Tel: +44 (0)1206 713 800

 

Shore Capital (Nominated Adviser and Broker)

Daniel Bush

Tom Knibbs

Tel: +44 (0)20 7408 4090

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRMMMTMTJBTII
Date   Source Headline
1st Jun 20267:00 amRNSAcquisition
30th Apr 20267:00 amRNSInterim results
17th Apr 20267:00 amRNSNotice of Interim Results & Investor Presentation
20th Mar 20267:00 amRNSResult of AGM
19th Mar 20267:00 amRNSAGM Trading Update
23rd Feb 20267:00 amRNS2025 Annual Report and Notice of AGM
15th Jan 20267:00 amRNSAnnual Financial Report
2nd Dec 20257:00 amRNSDirector/PDMR Shareholding
24th Nov 20257:00 amRNSHolding(s) in Company
17th Oct 20257:00 amRNSFull Year Trading Update
29th Sep 20252:18 pmRNSHolding(s) in Company
29th Sep 202512:42 pmRNSHolding(s) in Company
14th Jul 20257:00 amRNSHolding(s) in Company
11th Jul 20259:10 amRNSHolding(s) in Company
7th Jul 20259:01 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSDirector/PDMR Shareholding
30th Apr 20257:00 amRNSUnaudited Interim Results to 31 March 2025
25th Apr 20257:00 amRNSNotice of Interim Results & Investor Presentation
1st Apr 20257:00 amRNSHolding(s) in Company
25th Mar 20253:10 pmRNSResult of AGM
25th Mar 20257:00 amRNSAGM Trading Update
18th Mar 202512:03 pmRNSDirector/PDMR Shareholdings
3rd Mar 20257:00 amRNS2024 Annual Report and Notice of AGM
23rd Jan 20257:00 amRNSAnnual Financial Report
20th Jan 20257:00 amRNSNotice of Results and Investor Presentation
16th Dec 20247:00 amRNSCompletion of Disposal and Update on FY24 Results
29th Oct 20241:46 pmRNSDirector/PDMR Shareholdings
24th Oct 20247:00 amRNSCommencement of Process to Dispose of Korean Ops
3rd Sep 20247:00 amRNSNon-Executive Board Change
19th Jul 20242:05 pmRNSGrant of options and Director/PDMR Shareholding
11th Jul 20247:00 amRNSTrading Update and Board Change
15th May 20247:00 amRNSInterim Results for six months to 31 March 2024
25th Apr 20247:00 amRNSNotice of Interim Results & Investor Presentation
17th Apr 20242:15 pmRNSNotification of Major Holdings
2nd Apr 20242:43 pmRNSHolding(s) in Company
27th Mar 202411:28 amRNSResult of Annual General Meeting
26th Mar 20247:00 amRNSAGM Trading Update
27th Feb 20245:00 pmRNSDirector/PDMR Shareholding
26th Feb 20243:15 pmRNS2023 Annual Financial Report and Notice of AGM
25th Jan 20247:00 amRNSAnnual Financial Report year ended 30 Sept 2023
19th Jan 20241:07 pmRNSInvestor Presentation via Investor Meet Company
22nd Dec 20237:00 amRNSConfirmation of Board Appointment
5th Dec 20237:00 amRNSNotification of Major Holdings
4th Dec 20237:00 amRNSTrading Update
29th Nov 20237:00 amRNSNon-Executive Director Changes
22nd Nov 20237:00 amRNSAppointment of CEO
6th Oct 20234:00 pmRNSExercise of Options and Total Voting Rights
14th Sep 20233:45 pmRNSHolding(s) in Company
30th Aug 20232:17 pmRNSNotification of Major Holdings
4th Jul 20234:30 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.